Vietnam able to produce COVID-19 treatment drug Molnupiravir
Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat COVID-19 patients with mild or no symptoms, according to the Ministry of Health.
Hanoi (VNA) – Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat COVID-19 patients with mild or no symptoms,according to the Ministry of Health.
Of the three, the drug manufactured by Stellapharm Vietnamhas been approved for clinical trial. Because Molnupiravir has yet been grantedwith a circulation registration number in Vietnam, the Ministry of Health isconsidering asking the Government for approval of using the drug inemergency cases. If approved by the Government, it is expected that three registrationnumbers will be issued for three types of Molnupiravir drugs manufactured by domesticpharmaceutical companies.
Regarding the effectiveness of Molnupiravir on COVID-19 patients in Vietnam,the Department of Science, Technology and Training under the Ministry of Healthsaid that from the end of August, the ministry has piloted using Molnupiravirfor non-hospitalised patients. Ho Chi Minh City was the first locality to implementthis pilot programme. At present, it has been arried out in 34 provinces andcities.
The ministry has provided 110,000 doses, including 50,000doses of Molnupiravir 400 mg Stella VN, and 60,000 doses of Molnupiravir 200 mgOptimus produced by India to localities.
The use of the drug in 22 provinces and cities showthat Molnupiravir is safe and well-accepted, and has obvious effectiveness inreducing viral load, virus spread and the number of severe cases, andshortening treatment time, with no fatalities recorded.
Molnupiravir is developed by the US-based pharmaceuticalcompanies Ridgeback Biotherapeutics and Merck & Co., Inc./.
Deputy Minister of Health Tran Van Thuan held an online working session with France’s Xenothera company on cooperation to conduct the third phase of clinical trial of Xenothera-developed XAV-19 COVID-19 treatment drug and the transfer of XAV-19 production technology to Vietnam.
The Polysan Science & Technology Company in Saint-Petersburg has decided to grant a batch of Cytoflavin drug that is able to treat around 1,000 COVID-19 patients to the Vietnamese Ministry of Defence.
Vietnamese Ambassador to the US Ha Kim Ngoc has proposed Pfizer, one of the world's leading pharmaceutical and biotechnology companies, cooperate with Vietnam in the production of COVID-19 treatment drugs and promote to have an effective and safe vaccine for children.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
Molnupiravir pills (Photo: VNA) 
